CA 125 in benign gynecological conditions
- PMID: 10228907
- DOI: 10.1177/172460089801300411
CA 125 in benign gynecological conditions
Abstract
The tumor marker CA 125 was initially thought to be specific for ovarian malignancies. Subsequently it was found to be raised in a variety of benign conditions, including pregnancy, pelvic inflammatory disease, tuberculosis and cirrhosis of the liver. With respect to gynecological tumors, CA 125 may be elevated in benign ovarian cysts, tubo-ovarian abscess, endometriosis, hyperstimulation syndrome, ectopic pregnancy and fibroids. These results demonstrate that CA 125 is a marker of non-specific peritoneal conditions.
Similar articles
-
HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases.Tumour Biol. 2011 Dec;32(6):1087-95. doi: 10.1007/s13277-011-0204-3. Epub 2011 Aug 24. Tumour Biol. 2011. PMID: 21863264 Free PMC article.
-
Tissue polypeptide-specific antigen and CA 125 as serum tumor markers in ovarian carcinoma.Tumour Biol. 1994;15(6):361-7. doi: 10.1159/000217913. Tumour Biol. 1994. PMID: 7997808 Clinical Trial.
-
Diagnosis and Management of Adnexal Masses.Am Fam Physician. 2016 Apr 15;93(8):676-81. Am Fam Physician. 2016. PMID: 27175840 Review.
-
CA 125: the past and the future.Int J Biol Markers. 1998 Oct-Dec;13(4):179-87. doi: 10.1177/172460089801300402. Int J Biol Markers. 1998. PMID: 10228898 Review.
-
Cirrhotic ascites, ovarian carcinoma, and CA-125.South Med J. 1999 Feb;92(2):248-50. doi: 10.1097/00007611-199902000-00019. South Med J. 1999. PMID: 10071679
Cited by
-
Diagnostic role of urine human epididymis protein 4 in ovarian cancer.Biochem Med (Zagreb). 2024 Oct 15;34(3):030502. doi: 10.11613/BM.2024.030502. Biochem Med (Zagreb). 2024. PMID: 39435168 Free PMC article. Review.
-
Tumour markers: An overview.Indian J Clin Biochem. 2007 Sep;22(2):17-31. doi: 10.1007/BF02913308. Indian J Clin Biochem. 2007. PMID: 23105677 Free PMC article.
-
mRNA and Protein Expression in Human Fetal Membrane Cells: Potential Biomarkers for Preterm Prelabor Rupture of the Fetal Membranes?Int J Mol Sci. 2023 Oct 31;24(21):15826. doi: 10.3390/ijms242115826. Int J Mol Sci. 2023. PMID: 37958809 Free PMC article.
-
MicroRNAs as Potential Biomarkers in Gynecological Cancers.Biomedicines. 2023 Jun 13;11(6):1704. doi: 10.3390/biomedicines11061704. Biomedicines. 2023. PMID: 37371799 Free PMC article. Review.
-
Screening for ovarian cancer: imaging challenges and opportunities for improvement.Ultrasound Obstet Gynecol. 2018 Mar;51(3):293-303. doi: 10.1002/uog.17557. Ultrasound Obstet Gynecol. 2018. PMID: 28639753 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials